EZETIMIBE TEVA 10 mg, tablet 30 tablets, CIP 3400930059760
Active ingredients: Ezetimibe
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tablets, CIP 3400930059760orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EZETIMIBE TEVA 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66999267CIP73005976CIP133400930059760Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉZÉTIMIBEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.